These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2332985

  • 1. Acute myelofibrosis: response to recombinant human interferon alpha-2a.
    List AF, Kummet TD, Kerr DM.
    Leuk Res; 1990; 14(4):321-6. PubMed ID: 2332985
    [Abstract] [Full Text] [Related]

  • 2. Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia.
    Barosi G, Liberato LN, Costa A, Ascari E.
    Blut; 1989 Jun; 58(6):271-4. PubMed ID: 2736307
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination therapy with recombinant human erythropoietin, interferon-alpha-2b and granulocyte-macrophage colony-stimulating factor in idiopathic myelofibrosis.
    Bourantas KL, Tsiara S, Christou L, Repousis P, Konstantinidou P, Bai M, Seferiadis K.
    Acta Haematol; 1996 Jun; 96(2):79-82. PubMed ID: 8701705
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Alpha interferon treatment of idiopathic myelofibrosis].
    Cervantes F, Alcorta I, Escoda L, Montserrat E, Rozman C.
    Med Clin (Barc); 1993 Oct 23; 101(13):498-500. PubMed ID: 8231385
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hypothesis: a possible role for interferon in the treatment of idiopathic myelofibrosis.
    Hasselbalch H.
    Med Hypotheses; 1988 Dec 23; 27(4):345-7. PubMed ID: 3226365
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Circulating progenitor cells in myelofibrosis: the effect of recombinant alpha 2b interferon in vivo and in vitro.
    Craig JI, Anthony RS, Parker AC.
    Br J Haematol; 1991 Jun 23; 78(2):155-60. PubMed ID: 2064955
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of pegylated-interferon α-2a in myelofibrosis: a study by the FIM and GEM French cooperative groups.
    Ianotto JC, Boyer-Perrard F, Gyan E, Laribi K, Cony-Makhoul P, Demory JL, De Renzis B, Dosquet C, Rey J, Roy L, Dupriez B, Knoops L, Legros L, Malou M, Hutin P, Ranta D, Schoenwald M, Andreoli A, Abgrall JF, Kiladjian JJ.
    Br J Haematol; 2013 Sep 23; 162(6):783-91. PubMed ID: 23848933
    [Abstract] [Full Text] [Related]

  • 14. The effect of initial molecular profile on response to recombinant interferon-α (rIFNα) treatment in early myelofibrosis.
    Silver RT, Barel AC, Lascu E, Ritchie EK, Roboz GJ, Christos PJ, Orazi A, Hassane DC, Tam W, Cross NCP.
    Cancer; 2017 Jul 15; 123(14):2680-2687. PubMed ID: 28518222
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Spohr M, Diehl V, Zankovich R, Niederle N, Leder LD.
    Br J Haematol; 2000 Jan 15; 108(1):64-71. PubMed ID: 10651725
    [Abstract] [Full Text] [Related]

  • 17. Pegylated interferon for the treatment of early myelofibrosis: correlation of serial laboratory studies with response to therapy.
    O'Neill C, Siddiqi I, Brynes RK, Vergara-Lluri M, Moschiano E, O'Connell C.
    Ann Hematol; 2016 Apr 15; 95(5):733-8. PubMed ID: 26961933
    [Abstract] [Full Text] [Related]

  • 18. [Successful treatment of primary myelofibrosis with thrombocytosis during pregnancy with alfa-interferon].
    Gotić M, Cvetković M, Bozanović T, Cemerikić V.
    Srp Arh Celok Lek; 2001 Apr 15; 129(11-12):304-8. PubMed ID: 11928616
    [Abstract] [Full Text] [Related]

  • 19. A case of interstitial pneumonitis associated with natural alpha-interferon therapy for myelofibrosis.
    Nakamura F, Andoh A, Minamiguchi H, Hodohara K, Fujiyama Y, Bamba T.
    Acta Haematol; 1997 Apr 15; 97(4):222-4. PubMed ID: 9158665
    [Abstract] [Full Text] [Related]

  • 20. [Cytoreductive effect of recombinant alfa-interferon in patients with myelofibrosis with myeloid metaplasia].
    Barosi G, Liberato NL, Costa A, Ascari E.
    Haematologica; 1990 Apr 15; 75 Suppl 4():48-50. PubMed ID: 2074054
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.